EMA Panel Backs Belimumab for Children With Lupus EMA Panel Backs Belimumab for Children With Lupus

An EMA panel recommended extending the indication for belimumab to children aged 5 years and older with systemic lupus erythematosus.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news